JUPITER NEUROSCIENCES, INC.
Close on Oct 19, 2026
- Market cap
- $1.53M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Jupiter Neurosciences has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Jupiter Neurosciences filed with the SEC
Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Neurosciences, Inc. Announces Reverse Stock Split
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
Material agreement · Other events · EX-99.1 to Form 8-K
Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Jupiter Neurosciences Enters into Agreements
Material agreement · New financial obligation · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Neurosciences Regains Compliance with Nasdaq
Other events · EX-99.1 to Form 8-K
Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Neurosciences, Inc. Announces Closing of $11 million
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K